PATENT CLAIM ANALYSIS

Application Number: 16360811
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-09
Patent Classification: ["514", "235800"]

Abstract:
Compounds of formula (I) which are inhibitors of Bub 1 kinase, processes for their production and their use as pharmaceuticals.

Claim (Index 15):
A pharmaceutical composition comprising at least one compound of formula (I) according to  claim 1 , or an N-oxide, a pharmaceutically acceptable salt, a tautomer or a stereoisomer thereof, or a pharmaceutically acceptable salt of said N-oxide, tautomer or stereoisomer, together with at least one pharmaceutically acceptable auxiliary.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 99.0
- Lexical Diversity: 1.09091
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14350160', '14365895', '14400315', '14900599', '15032957']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8064826213685368
- 35 USC 102 Novelty (BERT): 0.6129608326594914
- Combined Prediction Score: 0.7871304424976323
- Mean Citation Score: 480.713422
- Max Citation Score: 558.1653
- Similarity Product: 507.32270835042

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test